News for Illumina, Inc. (ILMN)

Investors with significant funds have taken a bullish position in Illumina ILMN, a development that retail traders should be aware of. This was brought to our ...

Morning Reads

PR NewswireSAN DIEGO, March 10, 2025 Announces Fiscal Year 2025 Non-GAAP Diluted EPS of Approximately $4.50SAN DIEGO, March 10, 2025 /PRNewswire/ -- Illumi

Illumina lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its gene sequencers.

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are going to take a look at where Illumina, Inc.

China banned imports of Illumina's gene sequencers as new U.S. tariffs took effect, cutting its market access while Chinese rivals gain ground in the biotech sector.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

"No room left" rattles auto industry as tariffs send stocks spiraling lower. Walgreens gains on reports of Sycamore nearing $10B takeover. 23andMe committee rejects new Wojcicki proposal.

The CBOE market volatility index edged up 0.35 points after hitting a two-month high at 24.31 in the previous session. The benchmark S&P 500 logged its biggest one-day drop since mid-December and the Nasdaq closed lower by about 9% from its all-time high on Monday after the U.S. imposed 25% tariffs on imports from Mexico and Canada, and doubled duties on Chinese goods to 20%. China responded with additional tariffs of 10%-15% on selected U.S. imports and Canada has vowed to respond with immediate 25% tariffs.

Global auto stocks sold off and Mexico's currency weakened, after President Trump hit Mexico, Canada and China with tariffs, prompting retaliation from Beijing and Ottawa. In recent trading: **European indexes d

China imposed tariffs as high as 15% on US goods and banned exports to some defense companies in retaliation for the Trump administration’s new levy, escalating a t…

Shares of Illumina Inc (ILMN) fell 3.24% in mid-day trading on Feb 27. The stock reached an intraday low of $89.81, before recovering slightly to $91.00, do

**media[550320]**

Illumina, Inc. (NASDAQ:ILMN) AGBT Investor Session Conference February 25, 2025 11:00 AM ETCompany ParticipantsSalli Schwartz - Head of Investor...

Summary On February 24, 2025, Illumina Inc (ILMN) announced a significant expansion of its multiomics portfolio, introducing new technologies that span genomics

PR NewswireSAN DIEGO, Feb. 24, 2025 Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and

Summary On February 21, 2025, Illumina Inc (ILMN), a leader in next-generation sequencing technologies, announced a strategic collaboration with Broad Clinical

Beijing’s surprise move to blacklist Illumina Inc. has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant.

Investors are continuing to assess the impact of new LLMs in the AI industry. X.